Utama › Jangkitan Virus
Kajian klinikal Jangkitan Virus sedang mengambil peserta di AS
31 kajian untuk Jangkitan Virus sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Washington, DC12 kajian
- Houston, TX6 kajian
- Boston, MA6 kajian
- Baltimore, MD5 kajian
- Hialeah, FL5 kajian
- Columbus, OH4 kajian
- Dallas, TX4 kajian
- Atlanta, GA4 kajian
- Cincinnati, OH4 kajian
- San Francisco, CA3 kajian
- St. Louis, MO3 kajian
- Omaha, NE3 kajian
- Miami, FL3 kajian
- Tampa, FL3 kajian
- Boise, ID3 kajian
- Los Angeles, CA3 kajian
- Worcester, MA3 kajian
- Durham, NC3 kajian
- Salt Lake City, UT3 kajian
- New York City, NY3 kajian
Mengikut negeri
- Alabama3 kajian
- California11 kajian
- Colorado3 kajian
- Florida6 kajian
- Georgia5 kajian
- Idaho3 kajian
- Illinois3 kajian
- Kentucky3 kajian
- Louisiana3 kajian
- Maryland14 kajian
- Massachusetts6 kajian
- Michigan3 kajian
- Missouri4 kajian
- Nebraska3 kajian
- New York6 kajian
- North Carolina5 kajian
- Ohio9 kajian
- Pennsylvania5 kajian
- South Carolina3 kajian
- Texas9 kajian
- Utah4 kajian
- Virginia4 kajian
- Wilayah Columbia5 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
Umur 5 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
6 Months – 120 Years · Semua jantina · Dikemas kini 14 Sep 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
2 Months – 115 Years · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
36 Months – 22 Years · Semua jantina · Dikemas kini 4 Sep 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 4 Sep 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
Mengambil pesertaFasa 1/2
4 Weeks · Semua jantina · Dikemas kini 4 Sep 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Mengambil pesertaFasa 2
2 Days · Semua jantina · Dikemas kini 4 Sep 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 40 hingga 64 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
Mengambil pesertaKajian pemerhatian
Umur 1 hingga 120 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Mengambil pesertaFasa 1
Semua umur · Semua jantina · Dikemas kini 11 Jun 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Mengambil pesertaFasa 1/2
1 Month – 79 Years · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
6 Months · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jan 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Mengambil pesertaFasa 1
3 Months – 80 Years · Semua jantina · Dikemas kini 26 Jan 2026 · NCT04691622Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.